Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor

Collin, MP; Lobell, M; Hubsch, W; Brohm, D; Schirok, H; Jautelat, R; Lustig, K; Bomer, U; Vohringer, V; Heroult, M; Grunewald, S; Hess-Stumpp, H

Collin, MP (reprint author), Bayer AG, Drug Discovery, Dept Med Chem, Postfach 101709, D-42096 Wuppertal, Germany.

CHEMMEDCHEM, 2018; 13 (5): 437

Abstract

Rogaratinib (BAY 1163877) is a highly potent and selective small-molecule pan-fibroblast growth factor receptor (FGFR) inhibitor (FGFR1-4) for oral ap......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索